Join Cy and Emily on The High Rise as they explore the dynamic landscape of New Jersey's cannabis program. In this episode, they begin by delving into the recent amendments made by the Cannabis Regulatory Commission, prioritizing cannabis licensing for social equity applicants for three months starting September 27. The hosts discuss the implications of these changes, the focus on wholesale, distributor, and delivery licenses, and how it impacts diversely owned businesses.

The conversation continues as Cy and Emily address the grilling of the Cannabis Regulatory Committee of New Jersey before a Senate Judiciary Committee. Learn about the concerns raised, including cannabis accessibility to minors, the challenges faced by medical-only dispensaries, and the debate surrounding the state's expensive marijuana prices. They also shed light on Curaleaf's decision to reduce production amid claims of an ample marijuana supply in the state.

Discover the latest statistics and market trends in New Jersey, including the decline in the medical market and the impact on patient numbers. The hosts examine the state's current licensing status and the challenges posed by neighboring states' market expansion.

Headset

E139 - Jersey Strong? Social Equity, Curaleaf's Decisions, and Market Dynamics 26:42 Share

High Rise: Cannabis MSOs, Products & Market Analysis

Shownotes Transcript

E139 - Jersey Strong? Social Equity, Curaleaf's Decisions, and Market Dynamics